Patent · US Active

Rapid infusion of autologous bone marrow derived stem cells

US9393269B2 · kind B2 · utility

0Cited by
1References
49Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2014
Grant dateJul 19, 2016
Priority date
Expiry dateJun 5, 2034

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method and composition for the aspiration, processing, testing and infusion of bone marrow derived stem cells, as an adjuvant treatment in cardiovascular disorders. More specifically, the invention provides for the methods and compositions for the aspiration, analysis, processing, infusate preparation and infusion of bone-marrow derived stem cells, particularly in a rapid point-of-care environment, wherein a centrifugal fractionation and optically monitored separation of the bone marrow yield desired cellular product in the desired concentration and viscosity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.